Last reviewed · How we verify
NCT05468099
Aerosol Generation in Dental Clinics
NA trial testing Chlorhexidine mouthwash and Povidone-Iodine in Risk Reduction in 70 participants. Completed in 31 July 2024.
31 July 2024
Quick facts
| Lead sponsor | University of Alberta |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 70 |
| Start date | 29 March 2022 |
| Primary completion | 31 July 2024 |
| Estimated completion | 31 July 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Chlorhexidine mouthwash and Povidone-Iodine
- High volume evacuator
- High volume evactuator and saliva ejector
- Local Exhaust System
Conditions studied
- Risk Reduction — all drugs for Risk Reduction →
- Occupational Exposure — all drugs for Occupational Exposure →
- Dentist-Patient Transmission — all drugs for Dentist-Patient Transmission →
Sponsor
University of Alberta
Who can join
Eligibility, any sex, with Risk Reduction or Occupational Exposure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study examines 4 different methods to reduce dental bioaerosol spread in orthodontic procedures.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05468099
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Risk Reduction
Currently open trials in the same condition.
- NCT06529913 — Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases · NA · recruiting
- NCT06446427 — The Effect of Acute High Altitude Exposure on Rescuer Performance and Patient Care · NA · active not recruiting
- NCT06611462 — STRONG for Surgery & Strong for Life - Intensive Prehabilitation for Risk Reduction in Ventral Hernia Repair · NA · recruiting
- NCT06001892 — Tennessee Youth Prepared for Success · NA · active not recruiting
- NCT05712252 — Fall, Fracture and Frailty · active not recruiting
Other University of Alberta trials
Trials by the same sponsor.
- NCT03240900 — Electrical Stimulation for Improving Postoperative Breast Sensation · NA · not yet recruiting
- NCT04231760 — The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD · Phase 1, PHASE2 · not yet recruiting
- NCT06649604 — Reducing Pain From Retinal Laser With Vibrational Stimulation · NA · not yet recruiting
- NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
- NCT06920914 — Effects of Minimally vs. Ultra-Processed Diets on Potassium (K) Handling in CKD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05468099 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Alberta
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05468099.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing